Abrocitinib Achieves Early and Complete/Near-Complete Skin Clearance Plus Itch-Free State in Atopic Dermatitis: Phase 3 Pooled Post Hoc Analysis

Study limitation reported by the research below: “The full text provided is the EMA Summary of Product Characteristics (SmPC) for Cibinqo, not the journal article body; clinical efficacy data in the summary are drawn from the abstract and results sections only.”